+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06586203

Study of a Genomic Test to Predict and Manage Cardiorenal Risks in Adults with Type 2 Diabetes Using Personalized Polygenic Risk Scores to Improve Treatment Outcomes

Led by Optithera · Updated on 2024-09-19

2714

Participants Needed

2

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

This research aims to provide Real World Evidence on how knowing the results of a polygenic risk prediction test affects the management of heart and kidney complications in adults with type 2 diabetes T2D. The study compares patients who are informed of their genetic risk score with those who are not, evaluating whether this knowledge helps more patients meet recommended treatment goals over an 18-month period. Researchers focus on key health measures such as blood sugar, blood pressure, and kidney function to assess these outcomes. Participants are randomly assigned to two groups one group receives their polygenic risk score results at the start of the study, while the other group is tested but not initially informed of their results. The study involves saliva sampling for genetic testing, followed by regular clinic visits every three months for a total of seven visits over 18 months. During these visits, patients undergo health checkups and complete quality of life questionnaires. Throughout the study, researchers monitor participants blood sugar levels HbA1c, systolic blood pressure, urine albumin levels, and kidney filtration rates to see if treatment targets are better achieved with knowledge of genetic risk. Medication use for blood pressure, glucose, and lipids is also tracked. The study includes safety measures such as avoiding severe hypoglycemia and falls, with ongoing assessments at each visit to observe health changes over time.

CONDITIONS

Brief Title

Clinical Utility of a Genomic Predictor Test on the Management of Cardiorenal Complications of Type 2 Diabetes

Research Team

M

Marie-Renée Guertin, il,cra

J

Johanne Tremblay, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here